Amo Pharma Limited
- Address
- 1 Park Row
Sponsor Overview
Specializations
Pharmacokinetics and hepatic impairment
Amo Pharma Limited supports clinical research focused on how investigational treatments behave in people with liver dysfunction, with attention to changes in drug handling and systemic exposure in comparison with healthy subjects.
- Hepatic impairment
- Healthy subjects
- Safety and tolerability
- Drug disposition
The sponsor’s research interest includes understanding how liver impairment may alter absorption, metabolism, and clearance in clinical development.
Clinical pharmacology
The company’s trial activity reflects an emphasis on clinical pharmacology, particularly the evaluation of pharmacokinetic profiles in populations with differing hepatic function.
- Pharmacokinetic assessment
- Hepatic function
- Exposure comparison
These studies support the characterization of how a candidate therapy is processed in subjects with altered liver physiology.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Safety, Tolerability, and Pharmacokinetics of Tideglusib in Patients with Hepatic Impairment Compared to Healthy Controls |  Bulgaria | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Musculoskeletal Diseases1 trial238 other sponsors
- 2.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
1 centre- Address
- Georgi Kothcev Str 6, 5800 Pleven
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Amo Pharma Limited.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.